Actemra syringe — Blue Cross Blue Shield of Texas
systemic sclerosis associated interstitial lung disease
Initial criteria
- Requested for diagnosis of systemic sclerosis associated interstitial lung disease AND
- Request is for Actemra syringe (not ACTpen)
Approval duration
12 months